MENU
IOBT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
IO Biotech (IOBT) Ownership - Who owns IO Biotech?
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform... Show more
Profile
Industry
N/A
Address
Ole Maaloes Vej 3
Phone
+45 70702980
Employees
68
Web
https://www.iobiotech.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
119.24M
P/E Ratio
N/A
Total Cash
37.09M
Projected Growth
N/A
Total Debt
1.76M
Revenue
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
0.56
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
IOBT
Capitalization
119M
P/E Ratio
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash
37.1M
Total Cash/Share
0.56
Total Debt
1.76M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
26.4M
P/B Ratio
4.51
Cash Flow
N/A
Earnings
-1.49
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
66K
Current Ratio
2.32
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-96.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-113.23
Shares Held By Institutions
25.2M
Shares Outstanding - Current
65.9M
Total Liabilities
19.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
98.913
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IOBT showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Ole Maaloes Vej 3
Phone
+45 70702980
Employees
68
Web
https://www.iobiotech.com